Many studies also detected a decrease in symptoms of pain, weakness, and depression if IL-6 blockers were used, but it is difficult to identify whether the effect on one symptom reduced the other symptoms as well or whether IL-6 is responsible for the occurrence of each symptom individually. The gene discussed is IL6; the disease is major depressive disorder.